About this item:

103 Views | 40 Downloads

Author Notes:

Gerard Thomas Portela, Email: gtp14@pitt.edu

Dr Lilly Cheng Immergluck, Email: limmergluck@msm.edu

Guarantor - LCI. Study conception and design—LCI, SF, DS, SMR. Data acquisition—SF. Analysis and interpretation of results—AW, GTP, TL, AG, LCI, SF, SMR, DS. Draft manuscript preparation—GTP, LCI, SF. All authors reviewed the results and revised/approved the final version of the manuscript.

The authors would like to acknowledge the following individuals from Georgia EIP: Minerva Mendez and Amber Britton for the collection of non-invasive Staphylococcus aureus data; Shanita Shack for her work on geocoding all patients; Amy Tunali, Rahsaan Overton, and Stepy Thomas for their assistance with study design and data collection for invasive S. aureus.

Disclosure: None declared

Subjects:

Research Funding:

Georgia Emerging Infections Program surveillance of invasive S. aureus was funded though the Centers for Disease Control and Prevention (CDC) Emerging Infections Program (grant number U50CK000485). Surveillance of non-invasive S. aureus was funded through an agreement between Pfizer and Emory University (grant number CP154653).

Research reported in this publication was supported in part by funds received (PHS Grant UL1TR002378) from the Clinical and Translational Science Award Program, National Institutes of Health, as part of the Georgia Clinical & Translational Science Alliance (Georgia CTSA) (formerly, UL1RR025008, Atlanta Clinical and Translational Science Institute (ACTSI)); Grant Number G12-RR03034, a component of the National Institute of Health; Grant Number HS024338-01; K-08 Mentored Clinical Scientist Award, Agency for Healthcare Research & Quality; and Grant Number G08LM013190-0, National Library of Medicine.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Medicine, General & Internal
  • General & Internal Medicine
  • infectious diseases
  • epidemiology
  • public health
  • microbiology
  • COMMUNITY-ASSOCIATED MRSA
  • COLONIZATION
  • EPIDEMIOLOGY
  • DISEASE

Risk factors for non-invasive (skin and soft tissue) and invasive Staphylococcus aureus infections among children and adults living in southeastern USA: a retrospective cohort study

Journal Title:

BMJ OPEN

Volume:

Volume 12, Number 8

Publisher:

Type of Work:

Article | Final Publisher PDF

Abstract:

Objective To characterise individual and area-level risks associated with invasive or skin and soft tissue (SSTIs) Staphylococcus aureus infections comparing methicillin-resistant S. aureus (MRSA) with methicillin-sensitive S. aureus (MSSA); and highlight differences between children and adults. Setting A population-based study from 21 reporting laboratories located in Georgia Health District 3 (HD3), an eight-county catchment area around metro Atlanta. Participants A case is a resident of HD3 from whom S. aureus had been isolated in 2017. Primary outcome Culture-confirmed S. aureus infections, classified as skin and soft tissue (proxy for non-invasive) or invasive, by methicillin-sensitivity status. Results The incidence of SSTIs was 19.7/100 000, compared with 5.2/100 000 for invasive infections. Adults experienced higher rates of SSTIs (22.3/100 000) and invasive infections (6.7/100 000) compared with children with SSTIs (13.0/100 000) and invasive infections (1.3/100 000). Risks of MRSA versus MSSA SSTIs were similar for children and adults. Black individuals with SSTIs were more likely to have MRSA than white individuals (children (OR 1.43, 95% CI 1.16 to 1.76); adults (OR 1.24, 95% CI 1.08 to 1.42)). Adults with invasive MRSA were more likely to be black (adjusted OR 1.69, 95% CI 1.25 to 2.29) compared with those with invasive MSSA. Children with invasive MRSA were more likely from a racial-ethnic concentrated area (OR 4.66, 95% CI 1.85 to 11.71). Hotspots of MRSA were found in crowded areas with higher rates of black populations. Conclusions The risk of MRSA infections in children and adults can be defined by unique area-level sociodemographic characteristics which were distinct for those areas associated with MSSA infections. Place-based risks of MRSA or MSSA can be used to develop target public health interventions to decrease transmission and incidence.

Copyright information:

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/).
Export to EndNote